Abu-Qare AW, Abou-Donia MB. Sarin: health effects, metabolism, and methods of analysis. Food Chem Toxicol 2002 Oct;40(10):1327-33 [Abstract]

Audi J, Belson M, Patel M, et al. Ricin poisoning: a comprehensive review. JAMA 2005 Nov 9;294(18):2342-51 [Abstract]

Bijani KH, Moghadamnia AA. Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf 2002 Nov;53(3):422-4 [Abstract]

Blix H. Weapons of terror: freeing the world of nuclear, biological and chemical arms. WMDC (Weapons of Mass Destruction Commission) final report. Jun 1, 2006 [Full text]

Board on Chemical Sciences and Technology. Testing and evaluation of standoff chemical agent detectors. Washington, DC: National Academies Press, 2003 [Full text]

Bogucki S, Weir S. Pulmonary manifestations of intentionally released chemical and biological agents. Clin Chest Med 2002 Dec;23(4):777-94 [Abstract]

Bozeman WP, Dilbero D, Schauben JL. Bozeman WP, Dilbero D, Schauben JL. Biologic and chemical weapons of mass destruction. Emerg Med Clin North Am 2002 Nov;20(4):975-93 [Abstract]

Brennan RJ, Waeckerle JF, Sharp TW, et al. Chemical warfare agents: emergency medical and emergency public health issues. Ann Emerg Med 1999 Aug;34(2):191-204 [Full text]

CDC. Guidance for public health departments and clinicians caring for individuals who may have been recently exposed to polonium 210 (Po-210). Released Dec 5, 2006 [Full text]

CDC. Investigation of a ricin-containing envelope at a postal facility: South Carolina, 2003. MMWR 2003 Nov 21;52(46):1129-31 [Full text]

CDC. Shipping instructions for specimens collected from people who may have been exposed to chemical-terrorism agents. Released Jan 9, 2007 [Full text]

DHS. Chemical Facility Anti-Terrorism Standards. Interim final rule released Apr 2, 2007 [Full text]

Dudley JP. New challenges for public health care: biological and chemical weapons awareness, surveillance, and response. Biol Res Nurs 2003 Apr;4(4):244-50 [Abstract]

FDA. FDA approves drug to treat cyanide poisoning. Dec 15, 2006, news release [Full text]

Fitzgerald DJ, Sztajnkrycer MD, Crocco TJ. Chemical weapon functional exercise - Cincinnati: observations and lessons learned from a "typical medium-sized" city's response to simulated terrorism utilizing weapons of mass destruction. Public Health Rep 2003 May-Jun;118(3):205-14 [Abstract]

Franz DR, Jaax ND. Ricin toxin. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Chap 32. Washington, DC: Office of the Surgeon General, Borden INstitute, Walter Reed Army Medical Center [Full text]

GAO (Government Accountability Office). Public health preparedness: developing and acquiring medical countermeasures against chemical, biological, radiological, and nuclear agents. GAO-11-567T. Apr 13, 2011 [Full text]

GAO (US Government Accountability Office). Chemical, biological, radiological, and nuclear risk assessments: DHS should establish more specific guidance for their use. GAO-12-272. Jan 25, 2012 [Full text]

GAO (US Government Accountability Office). Homeland defense: planning, resourcing, and training issues challenge DOD's respond to domestic chemical, biological, radiological, nuclear, and high-yield explosive incidents. GAO-10-123. Oct 7, 2009 [Full text]

HHS. HHS public health emergency medical countermeasures enterprise strategy for chemical, biological, radiological and nuclear threats. Fed Regist 2007 Mar 20;72(53):13109-14 [Full text]

Hom GG. Chemical, biological, and radiological weapons: implications for optometry and public health. Optometry 2003 Feb;74(2):81-98 [Abstract]

Jortani SA, Snyder JW, Valdes R. The role of the clinical laboratory in managing chemical or biological terrorism. Clin Chem 2000;46:1883-93 [Full text]

Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 2002;40(6):803-1 [Abstract]

LaTourrette T, Davis LE, Howell DR, et al. Public health preparedness and response to chemical and radiological incidents. TR-719. Rand Corp technical report released Aug 18, 2009 [Full text]

Leikin JB, Thomas RG, Walter FG, et al. A review of nerve agent exposure for the critical care physician. Crit Care Med. 2002 Oct;30(10):2346-54 [Abstract]

Marconescu PS, Smallshaw JE, Pop LM, et al. Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication. Vaccine 2010 Jul 19;28(32):5315-22 [Abstract]

Martin CO, Adams HP Jr. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol 2003 Jan;60(1):21-5 [Abstract]

Matzo M, Wilkinson A, Lynn J, et al. Palliative care considerations in mass casualty events with scarce resources. Biosecur Bioterror 2009 Jul 27;7(20):199-210 [Abstract]

Mrvos R, Piposzar JD, Stein TM, et al. Regional pharmaceutical preparation for biological and chemical terrorism. J Toxicol Clin Toxicol 2003;41(1):17-21 [Abstract]

NAS/HHS. Chemical attack warfare agents, industrial chemicals and toxins. News & Terrorism: Communicating in a Crisis. 2004 [Fact sheet]

National Research Council, Committee on the Atmospheric Dispersion of Hazardous Material Releases. Tracking and predicting the atmospheric dispersion of hazardous releases: implications for homeland security. Washington, DC: National Academies, 2003 [Full text]

NIOSH (National Institute for Occupational Safety and Health). Guidance for protecting building environments from airborne chemical, biological, or radiological attacks. DHHS (NIOSH) Pub No. 2002-139, May 2002 [Full text]

NIOSH/DHS (National Institute for Occupational Safety and Health/Department of Homeland Security). Guidance for filtration and air-cleaning systems to protect building environments from airborne chemical, biological, or radiological attacks. DHHS (NIOSH) Publication No. 2003-136. Apr 2003 [Full text]

Niska RW, Burt CW. Training for terrorism-related conditions in hospitals: United States, 2003-04. Adv Data 2006 Dec 11;(380):1-9 [Full text]

Noort D, Benschop HP, Black RM. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol 2002 Oct 15;184(2):116-26 [Abstract]

O'Hara JM, Whaley K, Pauly M, et al. Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit. Vaccine 2012 Feb 8;30(7):1239-43 [Abstract]

Olson MA, Carra JH, Roxas-Duncan V, et al. Finding a new vaccine in the ricin protein fold. Protein Eng Des Sel 2004 Apr;17(4):391-7 [Abstract]

Page WF. Long-term effects of exposure to sarin and other anticholinesterase chemical warfare agents. Mil Med 2003;168(3):239-45 [Abstract]

Pieters J, Ploegh H. Chemical warfare and mycobacterial defense. Science 2003 Dec 12:302(5652):1900-2

Porche DJ. Biological and chemical bioterrorism agents. J Assoc Nurses AIDS Care. 2002 Sep-Oct;13(5):57-64 [Abstract]

Rose MA, Larrimore KL. Knowledge and awareness concerning chemical and biological terrorism: continuing education implications. J Contin Educ Nurs. 2002 Nov-Dec;33(6):253-8 [Abstract]

Schier JG, Patel MM, Belson MG, et al. Public health investigation after the discovery of ricin in a South Carolina postal facility. Am J Public Health 2007 Apr;97(Suppl 1):S152-7 [Abstract]

Shea DA, Gottron F. Small-scale terrorist attacks using chemical and biological agents: an assessment framework and preliminary comparisons. CRS Report for Congress. May 20, 2004 [Full text]

Siegel D, Younggren BN, Ness B, et al. Operation Castle Cascade: managing multiple casualties from a simulated chemical weapons attack. Mil Med 2003 May;168(5):351-4 [Abstract]

Smallshaw JE, Richardson JA, Pincus S, et al. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 2005 Sep 15;23(39):4775-84 [Abstract]

Stechmann B, Bai SK, Gobbo E, et al. Inhibition of retrograde transport protects mice from lethal ricin challenge. Cell 2010 Apr 16;141(2):231-42 [Full text]

Trust for America's Health. Public health laboratories: unprepared and overwhelmed. June 2003 [Full text]

Tucker JB. War of nerves: chemical warfare from World War I to Al-Qaeda. Center for Nonproliferation Studies. 2006 [Summary and ordering information]

USACHPPM (US Army Center for Health Promotion and Preventive Medicine). The medical NBC battlebook. Tech Guide 244. May 2000 [Full text]

Vitetta ES, Smallshaw JE, Coleman E, et al. A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci 2006 Feb 14;103(7):2268-73 [Abstract]

Volans GN, Karalliedde L. Long-term effects of chemical weapons. Lancet 2002 Dec;360(Suppl):s35-6 [Abstract]

Wetter DC, Danielle WE, Treser CD. Hospital preparedness for victims of chemical or biological terrorism. Am J Public Health 2001 May;91(5):710-6 [Abstract]

White SM. Chemical and biological weapons. Implications for anaesthesia and intensive care. Br J Anaesth 2002 Aug;89(2):306-24 [Abstract]

WHO. Chemical agents. Annex 1 in Public health response to biological and chemical weapons: WHO guidance. Ed 2. 2004 [Full text]

Williams BL, Magsumbol MS. Emergency preparedness among people living near US Army chemical weapons sites after September 11, 2001. Am J Public Health 2007 Sep 1;97(9):1601-6 [Abstract]

Yermakova A, Mantis NJ. Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB). Vaccine 2011 Oct 19;29(45):7925-35 [Abstract]

Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington, DC: Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center 1997 [Full text]